drugset
drugset / Trial / NCT03787186

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection

NCT03787186 ↗

Phase 1 Completed 8 enrolled Lakefront Biotherapeutics NV
Non-randomizedSequentialOpen-labelBasic science

Summary

The sponsor wants to investigate how well the test medicine is taken up by the body when given orally (by mouth) as a tablet or capsule and as a solution for infusion (into a vein). The capsule and the solution will be radiolabelled. 'Radiolabelled' means that the test medicine has a radioactive component which helps us to track where the test medicine is in the body.

Timeline

Start
2018-11-09
Primary completion
2019-01-17
Completion
2019-01-17

Drugs

EvaluationDrugModalityDoseRoute
Subject ZIRITAXESTAT Small molecule — Oral

Indications

No indication recorded.